Immune thrombocytopenia

Common Name(s)

Immune thrombocytopenia

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune thrombocytopenia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune thrombocytopenia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Immune thrombocytopenia" returned 402 free, full-text research articles on human participants. First 3 results:

Successful treatment of acquired hemophilia A associated with immune thrombocytopenia and joint hemarthrosis: A case report and literature review.
 

Author(s): Fang Wei

Journal: Medicine (Baltimore). 2018 Sep;97(38):e12044.

 

Acquired hemophilia A (AHA) is a rare bleeding disease caused by autoantibodies against factor VIII (FVIII). Spontaneous bleeding symptoms usually affect the skin, musco, muscle, and internal organs, while joint hemarthrosis in AHA is an extremely rare manifestation. AHA may have ...

Last Updated: 31 Dec 1969

Go To URL
Abnormal Expression of Long Noncoding RNAs in Primary Immune Thrombocytopenia: A Microarray Related Study.
 

Author(s): Tengda Li, Mingli Gu, Peng Liu, Yun Liu, Jie Guo, Weiwei Zhang, Anmei Deng, Cheng Qian

Journal: Cell. Physiol. Biochem.. 2018 ;48(2):618-632.

 

Long noncoding RNAs (lncRNAs) are important regulators of biological processes and they contribute to the pathological developments of various diseases, including autoimmune diseases. To gain the further understanding, we estimate the expression of lncRNAs in primary immune thrombocytopenia (ITP).

Last Updated: 31 Dec 1969

Go To URL
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation.
 

Author(s): Mingming Qu, Qiang Liu, Hong-Guo Zhao, Jun Peng, Heyu Ni, Ming Hou, A J Gerard Jansen

Journal: Ann. Hematol.. 2018 Sep;97(9):1701-1706.

 

Infectious complications are common and sometimes life threatening in patients with immune thrombocytopenia (ITP), mainly due to the immune-suppressive therapy. Recent evidence suggests a potential role of platelets in the inflammation process. In this clinical study, we further investigated ...

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Immune thrombocytopenia" returned 62 free, full-text review articles on human participants. First 3 results:

Fostamatinib for persistent/chronic adult immune thrombocytopenia.
 

Author(s): Adrian Newland, Eun-Ju Lee, Vickie McDonald, James B Bussel

Journal: Immunotherapy. 2018 01;10(1):9-25.

 

Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterized by phagocytosis and destruction of autoantibody-coated platelets via spleen tyrosine kinase (Syk)-mediated signal transduction in macrophages. Effectiveness of existing therapies varies, and even leading ...

Last Updated: 31 Dec 1969

Go To URL
Clinical updates in adult immune thrombocytopenia.
 

Author(s): Michele P Lambert, Terry B Gernsheimer

Journal: Blood. 2017 05;129(21):2829-2835.

 

Immune thrombocytopenia (ITP) occurs in 2 to 4/100‚ÄČ000 adults and results in variable bleeding symptoms and thrombocytopenia. In the last decade, changes in our understanding of the pathophysiology of the disorder have led to the publication of new guidelines for the diagnosis and ...

Last Updated: 31 Dec 1969

Go To URL
Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapy.
 

Author(s): David Buchbinder, Diane Nugent, Loan Hsieh

Journal:

 

Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia. In approximately one-third of cases, the duration of thrombocytopenia will extend beyond 12 months consistent with a diagnosis of chronic ITP. Minor bleeding manifestations ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia
 

Status: Not yet recruiting

Condition Summary: Immune Thrombocytopenia

 

Last Updated: 7 Apr 2018

Go to URL
A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
 

Status: Not yet recruiting

Condition Summary: Immune Thrombocytopenia

 

Last Updated: 5 Jan 2017

Go to URL
Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China
 

Status: Recruiting

Condition Summary: Immune Thrombocytopenia

 

Last Updated: 26 Oct 2017

Go to URL